HIGHLIGHTS
- who: Sungho Kim et al. from the Department of Surgery, Korea University College of Medicine, Seoul, Korea have published the Article: Can We Reboot the Role of Intraperitoneal Chemotherapy in the Treatment for Gastric Cancer with Peritoneal Carcinomatosis?: A Retrospective Cohort Study Regarding Minimally Invasive Surgery Conjoined with Intraperitoneal plus Systemic Chemotherapy, in the Journal: Cancers 2022, x of /2022/
- what: This study demonstrated the therapeutic potential of MIS conjoined IP plus systemic chemotherapy for GC patients with PC. Although the study showed the prognostic significance of IP chemotherapy, it is necu2010 First, long-term . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.